Posted in | News

Coal-Fired Plant will be among the World's most Energy-Efficient

ABB, the leading power and automation technology group, has won an order worth $62 million from the German utility, E.ON-Kraftwerke GmbH, to supply the complete process control system for a new high-efficiency power plant.
ABB will equip E.ON’s 1,100-megawatt (MW) hard-coal-fired power plant, Datteln Unit4, with a state-of-the-art power plant control system. The new plant located in Germany’s Rhein-Ruhr region will have a thermal efficiency of more than 45 percent, making it one of the world’s most energy efficient coal-fired plants.

"This order demonstrates the trust E.ON places in ABB's power plant control technology and expertise," said Peter Leupp, head of ABB's Power Systems division. "Our integrated systems combine the latest ABB platform with our extensive knowledge of power plant processes, resulting in very reliable operation, as well as reduced maintenance and operational costs."

ABB's scope of supply comprises a System 800xA control installation, with boiler protection, and all instrumentation. This includes electrical actuators, which will be integrated into the process control system via a Profibus network. ABB will also carry out the complete engineering, installation and commissioning. The order includes the option to deliver process control equipment for three similar power plants in the future.

ABB is the leading supplier of power plant control systems, instrumentation and electrical balance of plant applications. Since the product was launched three years ago, ABB has supplied more than 2,500 System 800xA control installations for a variety of industries, including power generation.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.